Biotools B&M Labs, S.A. is a Spanish biotechnology company with a global presence, created with the mission of combining scientific excellence with the development of quality solutions for its customers in the Life Sciences, Biomedical and Biotechnology sectors.
Since its foundation in 1996, Biotools has been one of the leading and most successful companies in developing Molecular Biology reagents and kits for detecting pathogens.
With a clear international vocation, Biotools currently markets its products in over 20 countries through distribution agreements or direct sales. Our expertise in PCR technology for more than 18 years is reflected in the various proprietary technologies, aiming always to provide customers with products and improved processes.
Biotools is responsible for most aspects related to product development, from the initial market-focused research to the development and manufacture of our products. This way, we guarantee the highest quality standards..
In order to achieve our aim of providing the best customer support, Biotools has based its activities on the following philosophy:
Biotools focuses its efforts on combining the expertise and experience of its human team and its own resources, with the collaboration of some of the main hospitals, universities and research centres in Europe, for the development of complete and integral solutions for the diagnostic area.
Biotools collaborates with the following organisations:
Biotools has an excellent reputation for quality, performance and service These qualities have established Biotools' credibility among its numerous customers and distributors.
Genetic Markers Diagnostic Kits.
Molecular developing medical diagnostic kits stabilized by Gelification, easy to handle and ready for use, for nucleic acid amplification and real time detection microplate.
Mycoplex. Food toxins.
Development of new bioreceptors.
Development of an ultra-low-cost Lab-on-a-chip microsystem.
Development of DNA-arrays, protein-arrays and Diagnostic Kits in genotyping applications, clinical diagnosis, pharmacogenomics and the food control.
Development of diagnostic kits for Tuberculosis and MRSA.
Developing a confirmatory diagnostic system for real-time PCR for Human Influenza (A / H1N1).